After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Most recently, Yahoo Finance reported about the stock as it publicized that Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Alnylam Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $156.04 and fluctuated between $157.96 as its day high and $153.25 as its day low. The current market capitalization of Alnylam Pharmaceuticals Inc is $19.65B. A total of 0.74 million shares were traded on the day, compared to an average of 859.00K shares.
In the most recent transaction, SHARP PHILLIP A sold 30,000 shares of ALNY for 151.34 per share on Feb 29 ’24. After the transaction, the Director now owns 0 company shares. In a previous transaction on Feb 28 ’24, Greenstreet Yvonne sold 2,932 shares at 155.31 per share. ALNY shares that Chief Executive Officer owns now total 48,128.
Among the insiders who sold shares, Garg Pushkal disposed of 574 shares on Feb 28 ’24 at a per-share price of $155.30. This resulted in the CMO & EVP Dev & Med Affairs holding 8,666 shares of ALNY after the transaction. In another insider transaction, Poulton Jeffrey V. sold 574 shares at $155.30 per share on Feb 28 ’24. Company shares held by the EVP, Chief Financial Officer now total 19,478.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ALNY has a high of $218.88 and a low of $143.52.
As of this writing, ALNY has an earnings estimate of -$1.18 per share for the current quarter. EPS was calculated based on a consensus of 21 estimates, with a high estimate of -$0.27 per share and a lower estimate of -$1.56. The company reported an EPS of $1.15 in the last quarter, which was 185.80% higher than expectations of -$1.34.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ALNY’s latest balance sheet shows that the firm has $2.44B in Cash & Short Term Investments as of fiscal 2021. There were $997.59M in debt and $695.71M in liabilities at the time. Its Book Value Per Share was -$1.75, while its Total Shareholder’s Equity was $588.20M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALNY is Buy with a score of 4.16.
